Boston University
Local delivery of small molecules utilizing nanofiber biomaterials control switch CAR T cell activity improving safety and efficacy in solid tumors
Abstract
dc:description.abstractWhile Chimeric Antigen Receptor (CAR) T cell therapies have massively improved treatment outcomes for lymphoma and multiple myeloma, many challenges remain for improving the efficacy and safety of CAR therapies. Specifically, treatment related adverse events are still a massive challenge for patients and clinicians with over 60% of CAR T cell patients in clinical trials experiencing a grade 3 or higher adverse event. One approach to mitigate these side effects is small molecule-controlled gene circuits. Several groups have explored different drug-inducible CAR circuits but deliver the drug at high concentrations systemically. Meanwhile biomaterials enable localized delivery of therapeutics to further regulate the spatial temporal profile of a small molecule or protein. To leverage the inducible gene circuits and biomaterials, we developed electrospun, hydrophobic nanofiber meshes that deliver small molecules for local CAR T cell activation. We demonstrate improved safety and efficacy in a model of mesothelioma without evidence of CAR T cell toxicity. Together, these results demonstrate a novel and robust approach to improve safety and efficacy in local cancer therapy.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Biomedical Engineering
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Adams, Sarah Catherine
- Advisors dc:contributor.advisor
-
- Wong, Wilson W.
- Grinstaff, Mark W.
Subjects
dc:subject × 1Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53096